Improving lives by providing better access to treatments Improving lives by providing better access to treatments Our ‘Access to Healthcare’ initiative aims to extend support to underserved communities affected by Non-Communicable Diseases
FIBRONEER™ Phase III program initiated FIBRONEER™ Phase III program initiated FIBRONEER™ Phase III program initiated globally to evaluate BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor
Building Lasting Partnerships for a Better Future Building Lasting Partnerships for a Better Future Working with the University of Georgia, we’ve co-created a sustainability training initiative that benefits people, animals and the planet.
Improving Access to Healthcare Improving Access to Healthcare According to the UN Sustainable Development Goals, almost half of the global population is not covered by essential health services.
preventive care cat veterinarian preventive care cat veterinarian What can we all, cat owners or veterinarians, do to promote cat health? Click to find out!
View from Both Sides of the Table View from Both Sides of the Table Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
The Goals to Improve Living with GPP The Goals to Improve Living with GPP An article that describes the current goals to improve the lives of those living with generalized pustular psoriasis
The digital therapeutic solution halving hospitalization rates The digital therapeutic solution halving hospitalization rates Around 750,000 people live with chronic heart failure in Canada. The Medly program empowers patients with heart failure to manage their condition
Our Partners_ViraTherapeutics Our Partners_ViraTherapeutics Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
More Green Overview More Green Overview Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
India: Many positive developments for the population India: Many positive developments for the population A conversation with interim country manager Sandip Agrawal about a young and growing country
The GPP Forum Report The GPP Forum Report The generalized pustular psoriasis (GPP) Forum Report summarizes and highlights the important moments form the multistakeholder GPP Forum
Making-more-health-together-2021 Making-more-health-together-2021 1,200 participants from around the world join virtual convention on November 11-12
Second cancer immunotherapy partnership with 3T Bio Second cancer immunotherapy partnership with 3T Bio Second cancer immunotherapy partnership with 3T Bio
MORE GREEN: Reducing emissions throughout the supply chain MORE GREEN: Reducing emissions throughout the supply chain How Thermo Fisher is contributing to the decarbonization of Boehringer Ingelheim’s supply chain by reducing their own emissions
On the path to decarbonization: How we reduce our emissions On the path to decarbonization: How we reduce our emissions How our sites Fornovo and Paulínia became carbon-neutral and support our recently SBTi-validated 2030 goals
Our Venture Fund on the search for groundbreaking trends Our Venture Fund on the search for groundbreaking trends The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs FIBRONEER™ Ph3 trials in patients with IPF & other PF-ILDs Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
The generalized pustular psoriasis (GPP) Forum 2023 The generalized pustular psoriasis (GPP) Forum 2023 An executive summary of the activities and key takeaways from the GPP Forum 2023
The little things The little things In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
The METAmorphosis The METAmorphosis At Boehringer Ingelheim’s META offices in the Middle East, Turkey and Africa all offices in the region are already free of single-use plastic.
Professor Richeldi treatment initiation Professor Richeldi treatment initiation Leading pulmonologist Professor Richeldi discusses why early initiation of treatment in Idiopathic Pulmonary Fibrosis is important.